Screener
Oruka Therapeutics, Inc. ORKA Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $29.15M+46.3% | $27.64M-63.2% | $28.99M+12.8% | $24.09M+29.0% | $19.93M+284% | ||
| $7.29M+41.2% | $6.79M-48.0% | $5.12M+36.2% | $4.34M+54.0% | $5.16M+209% | ||
| $36.43M+45.2% | $34.43M-60.9% | $34.11M+15.8% | $28.43M+32.3% | $25.09M+266% | ||
| -$36.43M-45.2% | -$34.43M+60.9% | -$34.11M-15.8% | -$28.43M-32.3% | -$25.09M-266% | ||
| $4.61M+12.9% | $4.85M+10.2% | $3.83M+363% | $3.86M+614% | $4.09M+2,010% | ||
| -$31.82M-51.5% | -$29.58M+64.7% | -$30.28M-5.8% | -$24.57M-10.5% | -$21M-197% | ||
| -$36.39M-45.2% | -$34.4M+60.9% | -$34.09M-15.8% | -$28.41M-32.2% | -$25.07M-265% | ||
| -$36.43M-45.2% | -$34.43M+60.9% | -$34.11M-15.8% | -$28.43M-32.3% | -$25.09M-266% |
FAQ
- Is Oruka Therapeutics, Inc. profitable?
- Oruka Therapeutics, Inc. is not currently profitable: it reported a net loss of $116.3M over the trailing twelve months.
- Where does Oruka Therapeutics, Inc.'s income statement data come from?
- Every line is extracted from Oruka Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.